2026-09-21T17:14:43Zhttps://wakespace.lib.wfu.edu/server/oai/request

oai:null:10339/361502026-09-02T14:54:32Zcom_10339_14934col_10339_38132

Ghaffar, Sajid 2011-09-08T08:35:58Z 2011-09-08T08:35:58Z 2011 https://wakespace.lib.wfu.edu/handle/10339/36150 At the onset of the Gulf War in 1992, the threat of chemical and biological weapons prompted the Department of Defense to seek a waiver from the Food and Drug Administration to use the investigational new drugs pyridostigmine bromide and botulism vaccine without first obtaining consent from those servicemen and women who would receive the drugs. The waiver was granted and came in the form of the Interim Rule, which permitted the use of investigational new drugs when consent could not be obtained because of "non-feasibility" and the nature of the military mission. The Interim Rule restricted the soldiers' rights to informed consent, but was it justified? en Wake Forest University Gulf War Interim Rule Investigational New Drugs pyridostigmine bromide ETHICAL CONSIDERATIONS OF THE USE OF INVESTIGATIONAL NEW DRUGS DURING THE GULF WAR Thesis Hall, Mark Hyde, Michael Coughlin, Christine Bioethics open.access